MA29015B1 - Agents de liaison specifiques de l'angiopoietine-2 - Google Patents

Agents de liaison specifiques de l'angiopoietine-2

Info

Publication number
MA29015B1
MA29015B1 MA29892A MA29892A MA29015B1 MA 29015 B1 MA29015 B1 MA 29015B1 MA 29892 A MA29892 A MA 29892A MA 29892 A MA29892 A MA 29892A MA 29015 B1 MA29015 B1 MA 29015B1
Authority
MA
Morocco
Prior art keywords
angiopoietin
specific binding
binding agents
agents
specific
Prior art date
Application number
MA29892A
Other languages
English (en)
French (fr)
Inventor
Jonathon Daniel Oliner
Kevin Graham
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/982,440 external-priority patent/US7658924B2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MA29015B1 publication Critical patent/MA29015B1/fr

Links

MA29892A 2004-10-19 2007-05-11 Agents de liaison specifiques de l'angiopoietine-2 MA29015B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62016104P 2004-10-19 2004-10-19
US10/982,440 US7658924B2 (en) 2001-10-11 2004-11-04 Angiopoietin-2 specific binding agents

Publications (1)

Publication Number Publication Date
MA29015B1 true MA29015B1 (fr) 2007-11-01

Family

ID=39608222

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29892A MA29015B1 (fr) 2004-10-19 2007-05-11 Agents de liaison specifiques de l'angiopoietine-2

Country Status (10)

Country Link
JP (2) JP2008520188A (https=)
CN (1) CN101495513B (https=)
BR (1) BRPI0518209A (https=)
EA (1) EA011866B1 (https=)
IL (1) IL182279A0 (https=)
MA (1) MA29015B1 (https=)
MX (1) MX2007004247A (https=)
RU (2) RU2404992C2 (https=)
SG (1) SG156668A1 (https=)
ZA (1) ZA200704020B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0518209A (pt) * 2004-10-19 2008-11-04 Amgen Inc agentes de ligação especìficos à angiopoietina-2
JO3182B1 (ar) * 2009-07-29 2018-03-08 Regeneron Pharma مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
MY162940A (en) 2009-08-19 2017-07-31 Eisai R&D Man Co Ltd Quinoline derivative-containing pharmaceutical composition
EA022546B1 (ru) * 2011-09-28 2016-01-29 Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук Способ торможения роста карциномы эрлиха у лабораторного животного
HUE034044T2 (en) * 2011-09-30 2018-01-29 Dana Farber Cancer Inst Inc Therapeutic peptides
KR102063028B1 (ko) * 2012-01-23 2020-01-07 리제너론 파아마슈티컬스, 인크. 항-ang2 항체를 함유하는 안정화된 제형
WO2014100834A1 (en) * 2012-12-21 2014-06-26 The Regents Of The University Of California Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
NZ714049A (en) * 2013-05-14 2020-05-29 Eisai R&D Man Co Ltd Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
AR100270A1 (es) * 2014-05-19 2016-09-21 Lilly Co Eli Anticuerpos ang2
PT3524595T (pt) 2014-08-28 2022-09-19 Eisai R&D Man Co Ltd Derivado de quinolina altamente puro e método para produção do mesmo
LT3263106T (lt) 2015-02-25 2024-01-10 Eisai R&D Management Co., Ltd. Chinolino darinių kartumo sumažinimo būdas
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
MX373231B (es) 2015-06-16 2020-05-08 Eisai R&D Man Co Ltd Agente anticancerigeno.
US12220398B2 (en) 2015-08-20 2025-02-11 Eisai R&D Management Co., Ltd. Tumor therapeutic agent
CN106075448A (zh) * 2016-07-25 2016-11-09 广州道瑞医药科技有限公司 Angpt2抑制剂在制备用于治疗血管瘤的药物中的应用
CN106512006A (zh) * 2016-07-25 2017-03-22 广州道瑞医药科技有限公司 Angpt2分泌抑制剂在制备用于治疗血管瘤的药物中的应用
US12303505B2 (en) 2017-02-08 2025-05-20 Eisai R&D Management Co., Ltd. Tumor-treating pharmaceutical composition
RU2019134940A (ru) 2017-05-16 2021-06-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Лечение гепатоцеллюлярной карциномы
CN109096368B (zh) * 2018-09-30 2021-07-20 华南理工大学 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用
US20220204603A1 (en) * 2019-02-25 2022-06-30 Pharmabcine Inc. Anti-ang2 antibody and use thereof
CN112126671B (zh) * 2020-08-18 2021-08-31 中山大学附属第五医院 无乳链球菌Streptococus agalactiae治疗子宫内膜异位症的应用
CN116265487B (zh) * 2021-12-16 2025-01-10 三优生物医药(上海)有限公司 抗ang2-vegf双特异性抗体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE241380T1 (de) * 1999-03-26 2003-06-15 Regeneron Pharma Modulierung der gefässepermeabilität mittels tie2 rezeptoraktivatoren
US6342219B1 (en) * 1999-04-28 2002-01-29 Board Of Regents, The University Of Texas System Antibody compositions for selectively inhibiting VEGF
AU784231B2 (en) * 2000-06-23 2006-02-23 Schering Aktiengesellschaft Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use (II)
US7205275B2 (en) * 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
ATE536868T1 (de) * 2001-10-12 2011-12-15 Monosolrx Llc Einheitliche filme als schnell auflösende verabreichungsformen enthaltend geschmacksmaskiereden stoff
BRPI0518209A (pt) * 2004-10-19 2008-11-04 Amgen Inc agentes de ligação especìficos à angiopoietina-2

Also Published As

Publication number Publication date
MX2007004247A (es) 2007-06-12
EA011866B1 (ru) 2009-06-30
JP2011207882A (ja) 2011-10-20
CN101495513A (zh) 2009-07-29
ZA200704020B (en) 2008-06-25
CN101495513B (zh) 2014-08-06
SG156668A1 (en) 2009-11-26
IL182279A0 (en) 2007-07-24
RU2010132956A (ru) 2012-02-10
RU2007118670A (ru) 2008-12-27
EA200700876A1 (ru) 2007-10-26
JP2008520188A (ja) 2008-06-19
BRPI0518209A (pt) 2008-11-04
RU2404992C2 (ru) 2010-11-27

Similar Documents

Publication Publication Date Title
MA29015B1 (fr) Agents de liaison specifiques de l'angiopoietine-2
NO20041907L (no) Angiopoietin-2 spesifikke bindinsmidler
EP1819385A4 (en) NEEDLE ACQUISITION MECHANISMS
SMT202000607T1 (it) Proteine leganti l'interleuchina-13
EP1771786A4 (en) SAMPLE PROCESSING SIMULTANEOUS
EP1896040A4 (en) Phosphoramidate alkylator PRODRUGS
EP1621603A4 (en) DETERGENT COMPOSITION
EP1746141A4 (en) THICKENER
EP1827473A4 (en) MODULATOR OF ALPHA SYNNUCLEINE TOXICITY
FR2871145B1 (fr) Distributeur d'applicateurs
DE60134988D1 (de) Verknüpfbare elastomerzusammensetzung
FR2875398B1 (fr) Implant articulaire d'interposition
EP1924684A4 (en) Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
EP1714656A4 (en) ED-71 preparation
MA28812B1 (fr) Combinaisons d'epothilone
FR2879635B1 (fr) Connecteur d'ossature
EP1704857A4 (en) ABCA1 STABILISATOR
FR2853380B1 (fr) Articulation elastique
EP1674486A4 (en) AFFINITY RESIN
EP1819722A4 (en) MODULATION OF OVULATION
GB2409587B (en) 'Kwicap'
GB0510474D0 (en) Q's vaginometer
EP1756276A4 (en) KRUST ANIMAL EXPRESSION VECTOR
FR2878004B3 (fr) Ferrure d'angle
FR2852042B1 (fr) Piece d'aretier